During classical tumor escape by downregulation of MHC molecules and antigens, CD8 T cells maintain their killing capacity [315], suggesting that it is beneficial to maintain or enhance the original natural killing pathways and new targets of T cells for the maintenance of TCR-T cell activity. This evidence concerns the gene HLA-C and neoplasm.